The interaction of metabolic factors with HCV infection: does it matter?
about
Hepatitis C Virus, Insulin Resistance, and SteatosisAtherosclerosis as Extrahepatic Manifestation of Chronic Infection with Hepatitis C VirusMetabolic alterations and hepatitis C: From bench to bedsideAntiviral treatment of hepatitis C virus infection and factors affecting efficacyPathogenesis and significance of hepatitis C virus steatosis: an update on survival strategy of a successful pathogenMetabolic factors and chronic hepatitis C: a complex interplayHepatocellular carcinoma in patients with chronic hepatitis C virus infection in the Asia-Pacific regionGut microbiota and host metabolism in liver cirrhosisLimiting the access to direct-acting antivirals against HCV: an ethical dilemma.Hepatitis C virus and metabolic disorder interactions towards liver damage and atherosclerosis.Hepatitis C viremia is associated with cytomegalovirus IgG antibody levels in HIV-infected women.Hepatitis B and C virus infection and diabetes mellitus: A cohort study.Prognostic implication of liver histology in patients with nonalcoholic fatty liver disease in diabetesInsulin resistance and steatosis in HBV-HCV co-infected patients: Role of PNPLA3 polymorphisms and impact on liver fibrosis progressionHepatitis C virus genotype 3: hope for nonresponders and patients with cirrhosis.FTO rs9939609 polymorphism is associated with metabolic disturbances and response to HCV therapy in HIV/HCV-coinfected patients.Host factor SAMHD1 restricts DNA viruses in non-dividing myeloid cellsIL28B gene polymorphisms and US liver fatty changes in patients who spontaneously cleared hepatitis C virus infectionAssociation of PNPLA3 I148M Variant With Chronic Viral Hepatitis, Autoimmune Liver Diseases and Outcomes of Liver TransplantationIdentification of matrine as a promising novel drug for hepatic steatosis and glucose intolerance with HSP72 as an upstream targetAssociated Factors for Metabolic Syndrome in the Older Adults with Chronic Virus Hepatitis in the Community.Metabolic disorders and steatosis in patients with chronic hepatitis C: metabolic strategies for antiviral treatments.Duplex High-Resolution Melting Assay for the Simultaneous Genotyping of IL28B rs12979860 and PNPLA3 rs738409 Polymorphisms in Chronic Hepatitis C PatientsIncreased phosphoenolpyruvate carboxykinase gene expression and steatosis during hepatitis C virus subgenome replication: role of nonstructural component 5A and CCAAT/enhancer-binding protein β.Hepatitis C Virus-Induced Degradation of Cell Death-Inducing DFFA-Like Effector B Leads to Hepatic Lipid Dysregulation.Improving treatment and liver fibrosis outcomes with metformin in HCV-HIV co-infected and HCV mono-infected patients with insulin resistance: study protocol for a randomized controlled trial.Viral hepatitis markers in liver tissue in relation to serostatus in hepatocellular carcinoma.Retrospective study of the associations between hepatitis C virus infection and metabolic factors.Hepatitis C virus and cardiovascular: A review.Small heterodimer partner 1 directly interacts with NS5A viral protein and has a key role in HCV related liver cell transformation.The impact of pegylated interferon and ribavirin combination treatment on lipid metabolism and insulin resistance in chronic hepatitis C patients.Pilot study of pioglitazone before HCV retreatment in HIV/HCV genotype 1-infected subjects with insulin resistance and previous nonresponse to peginterferon and ribavirin therapy: A5239.Hepatitis C virus diversity and hepatic steatosis.Is genotype 3 of the hepatitis C virus the new villain?Cardiovascular diseases and HCV infection: a simple association or more?Hepatitis B virus infection and metabolic syndrome: fact or fiction?Metabolic reprogramming: a hallmark of viral oncogenesis.Hepatitis C virus induces a prediabetic state by directly impairing hepatic glucose metabolism in mice.Insulin resistance as a predictor of early virologic response to HCV therapy among chronic HCV Egyptian patients.Hepatogenous diabetes: Is it time to separate it from type 2 diabetes?
P2860
Q26751755-E150D4FD-7A69-4784-80A0-D7741D68F8A1Q26765245-CC159951-B290-483A-8BF5-B0C45F174B09Q26773261-241EEFEF-B252-4D97-881F-EC14ED627D99Q26851810-593B1820-81DD-44A7-AA41-BABF63DD9073Q26861095-77A24718-7A4E-43EC-AA0A-884CFC7735F3Q27011787-51CDC26D-FEB5-4829-8D07-3518CD4E6C6AQ27026753-9DE97C32-1B54-4CD6-AED3-827CAE2CB1FDQ28085155-942CDC31-C79D-4140-B151-E2D9FA86BCF2Q30244361-3A7D4C24-3794-4D5A-823B-B168EFADCD5FQ30360538-4169562F-0ADD-41C0-964C-6BD5A29AD3DDQ31115875-361925C3-C6D4-45B8-93AD-BC5550553A12Q33870708-C43E8AD1-0B7F-4145-8F62-0399F5CD370FQ34205386-2C1BA7FA-1077-44F0-B73A-720F9A0E15D2Q34263370-657AA722-2279-4FFC-A939-D8BD8DBC2802Q34302745-25681E5A-CDAD-4214-AD87-9B2179321E45Q34474404-944483B7-CB0E-4040-9796-3287437B89A0Q34795512-66227AAC-A1A1-4E4B-9CB9-2B26E5E4CA21Q34923937-5E80ED47-178E-43B0-99BE-F09BC94B540BQ35667877-DF02E53A-D906-4BF1-BF06-899A888A67EBQ36016417-F461EC02-E366-4011-A160-FE89765ABCB3Q36017421-FA6FFCBE-A0FD-4900-AFF1-FFD3FCDF19F8Q36026554-9ED89026-B904-46EB-B6F9-C6E25F7CD1B1Q36184217-D8A6A532-25FF-4717-92AB-7A8AC4B7C90AQ36347839-11F77320-3BFC-4151-81FD-D7899F064410Q36736396-0E8DCE5D-EF05-42FB-BB34-A9C2DA76A923Q37113118-B40A0871-391D-4A1A-8B67-06028566BC6FQ37281965-E87B4776-916C-44F4-8555-FCC7B49B8B92Q37374053-5DB4E5C5-A889-4EEA-AD82-741B4E6FFA2DQ37610905-68D799C9-98B2-45C5-B64A-85764400BDE1Q37708986-0F7C4AF5-AB18-4C91-A4EC-43A5A07FA42EQ37711317-33E9E186-3BBB-4DC6-A705-816E7B802D60Q37720828-D957255F-5646-469D-8BCC-C87C232EADADQ38072721-67186794-41E9-433B-B551-7C2290C837BEQ38155123-71394575-7329-46AC-805D-6227E54F7991Q38167953-33B832D0-E673-495A-BB96-8DBB38D1E3C4Q38236996-A67D1F40-D637-4AA9-A2C9-454B8180325AQ38674284-E152146D-C78E-4707-A60C-D31F3AB73612Q38701810-34A8F734-5708-40BA-BBEA-8B602A4CD7D5Q38853078-431FF8C2-EF18-4608-A9B2-6F7C57E4DABCQ39036315-49CB4CF3-E8F9-40D2-BBF3-1D6D2899B5AF
P2860
The interaction of metabolic factors with HCV infection: does it matter?
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
The interaction of metabolic factors with HCV infection: does it matter?
@ast
The interaction of metabolic factors with HCV infection: does it matter?
@en
type
label
The interaction of metabolic factors with HCV infection: does it matter?
@ast
The interaction of metabolic factors with HCV infection: does it matter?
@en
prefLabel
The interaction of metabolic factors with HCV infection: does it matter?
@ast
The interaction of metabolic factors with HCV infection: does it matter?
@en
P1476
The interaction of metabolic factors with HCV infection: does it matter?
@en
P2093
Federico Salamone
Francesco Negro
P304
P356
10.1016/S0168-8278(12)60007-5
P478
56 Suppl 1
P577
2012-01-01T00:00:00Z